Operating margin moved 1745 bp higher
Operating margin changed +1745 basis points from the comparable as-filed period.
-3.56%→13.89%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →APPS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow increased 103.2%
Operating cash flow changed +103.2% from the comparable as-filed period.
$8.8M→$17.9M2 prior comparisons
Revenue increased 26.8%
Revenue changed +26.8% from the comparable as-filed period.
$130.9M→$166.0M2 prior comparisons
Working capital increased 151.6%
Working capital changed +151.6% from the comparable as-filed period.
$22.5M→$56.7M3 prior comparisons
Current assets increased 28.1%
Current assets changed +28.1% from the comparable as-filed period.
$260.2M→$333.3M3 prior comparisons
Gross margin moved 160 bp higher
Gross margin changed +160 basis points from the comparable as-filed period.
55.59%→57.20%2 prior comparisons
Gross profit increased 30.4%
Gross profit changed +30.4% from the comparable as-filed period.
$72.8M→$94.9M2 prior comparisons
Operating income changed across a sign change
Operating income changed +594.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$4.7M→$23.1M2 prior comparisons
Shares outstanding increased 11.9%
Shares outstanding changed +11.9% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
108,127,174→121,016,2508 prior comparisons
Trade receivables increased 29.0%
Trade receivables changed +29.0% from the comparable as-filed period.
$203.9M→$263.1M3 prior comparisons
Stock-based compensation decreased 60.9%
Stock-based compensation changed -60.9% from the comparable as-filed period.
$6.3M→$2.4M2 prior comparisons
SBC / revenue moved 331 bp lower
SBC / revenue changed -331 basis points from the comparable as-filed period.
4.79%→1.47%2 prior comparisons
Cash & equivalents increased 28.4%
Cash & equivalents changed +28.4% from the comparable as-filed period.
$33.4M→$42.9M3 prior comparisons
Working capital / assets moved 397 bp higher
Working capital / assets changed +397 basis points from the comparable as-filed period.
2.75%→6.72%3 prior comparisons
Cash / debt moved 382 bp higher
Cash / debt changed +382 basis points from the comparable as-filed period.
8.35%→12.17%2 prior comparisons
Receivables / revenue moved 277 bp higher
Receivables / revenue changed +277 basis points from the comparable as-filed period.
155.71%→158.49%2 prior comparisons
Operating cash-flow margin moved 405 bp higher
Operating cash-flow margin changed +405 basis points from the comparable as-filed period.
6.71%→10.76%2 prior comparisons
Debt / assets moved 711 bp lower
Debt / assets changed -711 basis points from the comparable as-filed period.
48.94%→41.83%3 prior comparisons
Debt / revenue moved 9331 bp lower
Debt / revenue changed -9331 basis points from the comparable as-filed period.
305.90%→212.59%2 prior comparisons
Current liabilities increased 16.4%
Current liabilities changed +16.4% from the comparable as-filed period.
$237.7M→$276.6M3 prior comparisons
Net debt decreased 15.6%
Net debt changed -15.6% from the comparable as-filed period.
$367.1M→$309.9M2 prior comparisons
Noncurrent long-term debt decreased 14.2%
Noncurrent long-term debt changed -14.2% from the comparable as-filed period.
$400.5M→$343.5M3 prior comparisons
Gross debt decreased 11.9%
Gross debt changed -11.9% from the comparable as-filed period.
$400.5M→$352.9M3 prior comparisons
Reported total debt decreased 11.9%
Reported total debt changed -11.9% from the comparable as-filed period.
$400.5M→$352.9M3 prior comparisons
R&D / revenue moved 137 bp lower
R&D / revenue changed -137 basis points from the comparable as-filed period.
7.75%→6.38%2 prior comparisons
Total assets increased 3.1%
Total assets changed +3.1% from the comparable as-filed period.
$818.4M→$843.5M3 prior comparisons
Current ratio increased 10.1%
Current ratio changed +10.1% from the comparable as-filed period.
1.09→1.23 prior comparisons
Research & development increased 4.4%
Research & development changed +4.4% from the comparable as-filed period.
$10.1M→$10.6M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.